Cytokinetics, Inc. (NASDAQ: CYTK) Shares Rally After Strong Clinical Results From Its Heart Disease Treatment Candidate
Cytokinetics, Inc. (NASDAQ: CYTK) is engaged as a late-stage biopharmaceutical company, which is focused on the research, development, and commercialization ...
